Panacos Pharmaceuticals, Inc. (NASDAQOTH:PANC.PK)

CAPS Rating: 2 out of 5

A development stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other major human viral diseases.

Featured Broker Partners


Advertisement